Joint Letter with ALS Canada to the Canadian Agency for Drugs and Technologies in Health (CADTH)
Submitted to Suzanne McGurn, President and CEO, Canadian Agency for Drugs and Technologies in Health (CADTH), and Minister of Health, Mark Holland November 30, 2023Suzanne McGurnPresident and CEOCanadian Agency for Drugs and Technologies in Health (CADTH)865 Carling Ave., Suite 600Ottawa, ON, Canada, K1S 5S8 Dear Ms. McGurn, Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive, […]